Global Glycated Albumin Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Glycated Albumin Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Diabetes afflicts an increasing number of people worldwide each year. Proper blood glucose control is essential in preventing complications associated with diabetes, such as neuropathy, nephropathy and retinopathy.



Glycation is the result of a sugar molecule, such as fructose or glucose, bonding to a protein or lipid molecule without the controlling action of an enzyme. It is a haphazard process that impairs the functioning of biomolecules. The high levels of glucose present in diabetes meatus results in increased glycation of all proteins, including, albumin. Measurement of the amount of the glycation reaction resulting from the combination of glucose with free amino groups in proteins present in the blood is used to monitor the level of glucose that has generally been present in body fluids over a preceding period.



Thus serum glycated albumin assay can be used to determine the current level of glycation of albumin, the most abundant plasma protein. Hence, the gycated albumin assay may be used as a marker of glycemic control in diabetes and reflects glycemic control over the precious 2 to 4 weeks.

According to our (Global Info Research) latest study, the global Glycated Albumin market size was valued at US$ 465 million in 2023 and is forecast to a readjusted size of USD 643 million by 2030 with a CAGR of 4.8% during review period.

The major players in global Glycated Albumin market include Asahi Kasei Pharma, DIAZYME, Abnova, etc. The top 3 players occupy about 85% shares of the global market. Asia-Pacific and Europe are main markets, they occupy about 60% of the global market. Glycated Albumin (Animal) is the main type, with a share about 60%. Hospitals and Clinics is the main application, which holds a share about 50%.

This report is a detailed and comprehensive analysis for global Glycated Albumin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Glycated Albumin market size and forecasts, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2019-2030

Global Glycated Albumin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2019-2030

Global Glycated Albumin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2019-2030

Global Glycated Albumin market shares of main players, shipments in revenue ($ Million), sales quantity (K MT), and ASP (USD/MT), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Glycated Albumin

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Glycated Albumin market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Asahi Kasei Pharma, DIAZYME, Abnova, LifeSpan, Exocell, BSBE, Medicalsystem, Maccura, Leadman, Simes Sikma, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Glycated Albumin market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Glycated Albumin (Human)
Glycated Albumin (Animal)

Market segment by Application
Hospitals and Clinics
Laboratories

Major players covered
Asahi Kasei Pharma
DIAZYME
Abnova
LifeSpan
Exocell
BSBE
Medicalsystem
Maccura
Leadman
Simes Sikma
NINGBO PUREBIO

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Glycated Albumin product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Glycated Albumin, with price, sales quantity, revenue, and global market share of Glycated Albumin from 2019 to 2024.

Chapter 3, the Glycated Albumin competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Glycated Albumin breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Glycated Albumin market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Glycated Albumin.

Chapter 14 and 15, to describe Glycated Albumin sales channel, distributors, customers, research findings and conclusion.